Results 11 to 20 of about 183,058 (174)
Novel teprotumumab treatment of severe thyroid dermopathy; ototoxicity as an adverse side effect [PDF]
Dermatology Online Journal, 2023 Pretibial myxedema, more generally thyroid dermopathy, results from mucopolysaccharide accumulation in the dermis, typically between the knee and dorsal foot. Thyroid dermopathy presents in Graves disease, but can occur in Hashimoto thyroiditis, primary hypothyroidism, and euthyroid patients.
Patel, Riya T +2 more
openaire +5 more sources
Alemtuzumab-Induced Graves' Disease Complicated by Pretibial Myxoedema: A Case Report. [PDF]
Case Rep EndocrinolBackground Alemtuzumab, a monoclonal antibody targeting CD52, is associated with a high incidence of secondary autoimmune disease, most commonly thyroid dysfunction. Alemtuzumab‐induced Graves’ disease (AIGD) typically follows a relapsing course and may exhibit atypical or severe phenotypes during immune reconstitution (IR). Case Presentation We report
O'Brolchain A, Reda E.
europepmc +2 more sources
TEMPORAL RELATIONSHIP BETWEEN THE ONSET OF THYROID DERMOPATHY AND GRAVES' OPHTHALMOPATHY
Acta Medica Iranica, 1993 Pretibial myxedema is an uncommon manifestation of Graves' disease and because of its rarity, information regarding its natural course and its relationship with other manifestations of Graves' disease is not sufficient.
Mohammad Pajhouhi
doaj +1 more source
Euthyroid Pretibial Mucinous Dermatoses: A Systematic Review of Current Evidence and the Controversy Surrounding Their Classification [PDF]
Acta Dermato-VenereologicaGhassan Barnawi +4 more
doaj +2 more sources
Pretibial myxedema in a euthyroid patient: a case report
Thyroid Research, 2021 Background Pretibial myxedema also known as localized myxedema, thyroid dermopathy, or infiltrative dermopathy and rarely as localized mucinosis is an infrequent manifestation of Graves’ disease.
Rediet Ambachew +6 more
doaj +1 more source
Unilateral Grave’s Disease: A Rare Variant [PDF]
Journal of Clinical and Diagnostic Research, 2019 Grave’s Disease (GD), an autoimmune disorder, usually presents as diffuse goitre with involvement of both lobes of the thyroid gland. It is characterised by hyperthyroidism, ophthalmopathy and rarely dermopathy.
Arun Pande, Ajay Aggarwal, Roopak Wadhwa
doaj +1 more source
Successful therapeutic approach in a patient with elephantiasic pretibial myxedema, [PDF]
Anais Brasileiros de Dermatologia, 2020 Localized pretibial myxedema is a dermopathy whose treatment is a challenge in dermatology, occurring in 0.5-4% of patients with Graves’ disease. This autoimmune thyroid condition stimulates the production of hyaluronic acid and glycosaminoglycans that ...
Marina Ferreira +3 more
doaj +1 more source
The Concise Guide to PHARMACOLOGY 2023/24: Transporters
British Journal of Pharmacology, Volume 180, Issue S2, Page S374-S469, October 2023., 2023 The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and over 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links
Stephen P. H. Alexander +27 more
wiley +1 more source
Thyroid Disorders and Movement Disorders—A Systematic Review
Movement Disorders Clinical Practice, Volume 10, Issue 3, Page 360-368, March 2023., 2023 Abstract Background There is overlap between movement disorders and neuroendocrine abnormalities. Objectives and methods To provide a systematic review on the association of thyroid dysfunction and movement disorders. Thyroid physiological function and classical thyroid disorders highlighting typical and atypical manifestations including movement ...
Susanne A. Schneider +2 more
wiley +1 more source